Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of NPC1L1 disrupts adaptive responses of drug‐tolerant persister cells to chemotherapy
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 14, Issue 2, Pages -
Publisher
EMBO
Online
2022-01-13
DOI
10.15252/emmm.202114903
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An Embryonic Diapause-like Adaptation with Suppressed Myc Activity Enables Tumor Treatment Persistence
- (2021) Eugen Dhimolea et al. CANCER CELL
- Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy
- (2021) Sumaiyah K. Rehman et al. CELL
- The role of endolysosomal trafficking in anticancer drug resistance
- (2021) Noor A. Hussein et al. DRUG RESISTANCE UPDATES
- Cycling cancer persister cells arise from lineages with distinct programs
- (2021) Yaara Oren et al. NATURE
- Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
- (2020) Jinyun Dong et al. DRUG RESISTANCE UPDATES
- Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
- (2020) Sabrina Dallavalle et al. DRUG RESISTANCE UPDATES
- Oxidative Stress in Cancer
- (2020) John D. Hayes et al. CANCER CELL
- Targeting Cancer Cell Dormancy
- (2019) Ariadna Recasens et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Definitions and guidelines for research on antibiotic persistence
- (2019) Nathalie Q. Balaban et al. NATURE REVIEWS MICROBIOLOGY
- What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
- (2019) Teodora Alexa-Stratulat et al. DRUG RESISTANCE UPDATES
- Adaptive evolution reveals a tradeoff between growth rate and oxidative stress during naphthoquinone-based aerobic respiration
- (2019) Amitesh Anand et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets
- (2019) Joanna Kopecka et al. DRUG RESISTANCE UPDATES
- Advanced technological tools to study multidrug resistance in cancer
- (2019) Luca Andrei et al. DRUG RESISTANCE UPDATES
- An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells
- (2019) Shensi Shen et al. Nature Communications
- Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance
- (2018) Nobuaki Takahashi et al. CANCER CELL
- An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
- (2018) Liqin Wang et al. CELL
- Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
- (2018) Hai Wang et al. Nature Communications
- Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer
- (2018) Tyler Risom et al. Nature Communications
- Inhibiting Cholesterol Absorption During Lactation Programs Future Intestinal Absorption of Cholesterol in Adult Mice
- (2017) Lidiya G. Dimova et al. GASTROENTEROLOGY
- Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
- (2017) Matthew J. Hangauer et al. NATURE
- Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
- (2017) Vasanthi S. Viswanathan et al. NATURE
- Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
- (2017) Rémy Nicolle et al. Cell Reports
- An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
- (2016) Maia Vinogradova et al. Nature Chemical Biology
- Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs
- (2016) Nisebita Sahu et al. Nature Communications
- The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
- (2014) D. Raha et al. CANCER RESEARCH
- Epigenetic Modulation of Intestinal Cholesterol Transporter Niemann-Pick C1-like 1 (NPC1L1) Gene Expression by DNA Methylation
- (2014) Pooja Malhotra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1
- (2013) Pei-Shan Li et al. NATURE MEDICINE
- Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5
- (2012) Dong-Yun Ouyang et al. Autophagy
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake
- (2010) L. Ge et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Is resistance useless? Multidrug resistance and collateral sensitivity
- (2009) Matthew D. Hall et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Niemann-Pick C1-Like 1 Mediates -Tocopherol Transport
- (2008) K. Narushima et al. MOLECULAR PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started